February  2004, 4(1): 135-146. doi: 10.3934/dcdsb.2004.4.135

Optimal control applied to immunotherapy

1. 

Department of Mathematics, University of Kentucky, Lexington, KY 40504, United States

2. 

Department of Mathematics and Statistics, Murray State University, 6C Faculty Hall, Murray, KY 42071, United States, United States

Received  August 2002 Revised  September 2003 Published  November 2003

We investigate a mathematical model for the dynamics between tumor cells, immune-effector cells, and the cytokine interleukin-2 (IL-2). In order to better determine under what circumstances the tumor can be eliminated, we implement optimal control theory. We design the control functional to maximize the effector cells and interleukin-2 concentration and to minimize the tumor cells. Next, we show that an optimal control exists for this problem. After which, we characterize our unique optimal control in terms of the solutions to the optimality system, which is the state system coupled with the adjoint system. Finally, we analyze the optimal control and optimality system using numerical techniques.
Citation: Thalya Burden, Jon Ernstberger, K. Renee Fister. Optimal control applied to immunotherapy. Discrete & Continuous Dynamical Systems - B, 2004, 4 (1) : 135-146. doi: 10.3934/dcdsb.2004.4.135
[1]

K. Renee Fister, Jennifer Hughes Donnelly. Immunotherapy: An Optimal Control Theory Approach. Mathematical Biosciences & Engineering, 2005, 2 (3) : 499-510. doi: 10.3934/mbe.2005.2.499

[2]

Urszula Ledzewicz, Heinz Schättler. Drug resistance in cancer chemotherapy as an optimal control problem. Discrete & Continuous Dynamical Systems - B, 2006, 6 (1) : 129-150. doi: 10.3934/dcdsb.2006.6.129

[3]

Hsiu-Chuan Wei. Mathematical and numerical analysis of a mathematical model of mixed immunotherapy and chemotherapy of cancer. Discrete & Continuous Dynamical Systems - B, 2016, 21 (4) : 1279-1295. doi: 10.3934/dcdsb.2016.21.1279

[4]

Urszula Ledzewicz, Heinz Schättler, Mostafa Reisi Gahrooi, Siamak Mahmoudian Dehkordi. On the MTD paradigm and optimal control for multi-drug cancer chemotherapy. Mathematical Biosciences & Engineering, 2013, 10 (3) : 803-819. doi: 10.3934/mbe.2013.10.803

[5]

Shuo Wang, Heinz Schättler. Optimal control of a mathematical model for cancer chemotherapy under tumor heterogeneity. Mathematical Biosciences & Engineering, 2016, 13 (6) : 1223-1240. doi: 10.3934/mbe.2016040

[6]

K. E. Starkov, Svetlana Bunimovich-Mendrazitsky. Dynamical properties and tumor clearance conditions for a nine-dimensional model of bladder cancer immunotherapy. Mathematical Biosciences & Engineering, 2016, 13 (5) : 1059-1075. doi: 10.3934/mbe.2016030

[7]

Shuo Wang, Heinz Schättler. Optimal control for cancer chemotherapy under tumor heterogeneity with Michealis-Menten pharmacodynamics. Discrete & Continuous Dynamical Systems - B, 2019, 24 (5) : 2383-2405. doi: 10.3934/dcdsb.2019100

[8]

Alexis B. Cook, Daniel R. Ziazadeh, Jianfeng Lu, Trachette L. Jackson. An integrated cellular and sub-cellular model of cancer chemotherapy and therapies that target cell survival. Mathematical Biosciences & Engineering, 2015, 12 (6) : 1219-1235. doi: 10.3934/mbe.2015.12.1219

[9]

Amina Eladdadi, Noura Yousfi, Abdessamad Tridane. Preface: Special issue on cancer modeling, analysis and control. Discrete & Continuous Dynamical Systems - B, 2013, 18 (4) : i-iii. doi: 10.3934/dcdsb.2013.18.4i

[10]

Urszula Ledzewicz, Heinz Schättler, Shuo Wang. On the role of tumor heterogeneity for optimal cancer chemotherapy. Networks & Heterogeneous Media, 2019, 14 (1) : 131-147. doi: 10.3934/nhm.2019007

[11]

Ben Sheller, Domenico D'Alessandro. Analysis of a cancer dormancy model and control of immuno-therapy. Mathematical Biosciences & Engineering, 2015, 12 (5) : 1037-1053. doi: 10.3934/mbe.2015.12.1037

[12]

Benedetto Piccoli. Optimal syntheses for state constrained problems with application to optimization of cancer therapies. Mathematical Control & Related Fields, 2012, 2 (4) : 383-398. doi: 10.3934/mcrf.2012.2.383

[13]

Wei Feng, Shuhua Hu, Xin Lu. Optimal controls for a 3-compartment model for cancer chemotherapy with quadratic objective. Conference Publications, 2003, 2003 (Special) : 544-553. doi: 10.3934/proc.2003.2003.544

[14]

Urszula Ledzewicz, Heinz Schättler. The Influence of PK/PD on the Structure of Optimal Controls in Cancer Chemotherapy Models. Mathematical Biosciences & Engineering, 2005, 2 (3) : 561-578. doi: 10.3934/mbe.2005.2.561

[15]

Ellina Grigorieva, Evgenii Khailov. Optimal control of pollution stock. Conference Publications, 2011, 2011 (Special) : 578-588. doi: 10.3934/proc.2011.2011.578

[16]

Hang-Chin Lai, Jin-Chirng Lee, Shuh-Jye Chern. A variational problem and optimal control. Journal of Industrial & Management Optimization, 2011, 7 (4) : 967-975. doi: 10.3934/jimo.2011.7.967

[17]

Denise E. Kirschner, Alexei Tsygvintsev. On the global dynamics of a model for tumor immunotherapy. Mathematical Biosciences & Engineering, 2009, 6 (3) : 573-583. doi: 10.3934/mbe.2009.6.573

[18]

Qun Lin, Ryan Loxton, Kok Lay Teo. The control parameterization method for nonlinear optimal control: A survey. Journal of Industrial & Management Optimization, 2014, 10 (1) : 275-309. doi: 10.3934/jimo.2014.10.275

[19]

Cristiana J. Silva, Helmut Maurer, Delfim F. M. Torres. Optimal control of a Tuberculosis model with state and control delays. Mathematical Biosciences & Engineering, 2017, 14 (1) : 321-337. doi: 10.3934/mbe.2017021

[20]

Jorge San Martín, Takéo Takahashi, Marius Tucsnak. An optimal control approach to ciliary locomotion. Mathematical Control & Related Fields, 2016, 6 (2) : 293-334. doi: 10.3934/mcrf.2016005

2018 Impact Factor: 1.008

Metrics

  • PDF downloads (9)
  • HTML views (0)
  • Cited by (0)

Other articles
by authors

[Back to Top]